1. Home
  2. INTS vs FTEL Comparison

INTS vs FTEL Comparison

Compare INTS & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • FTEL
  • Stock Information
  • Founded
  • INTS 2012
  • FTEL 2007
  • Country
  • INTS United States
  • FTEL Australia
  • Employees
  • INTS N/A
  • FTEL N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • FTEL
  • Sector
  • INTS Health Care
  • FTEL
  • Exchange
  • INTS Nasdaq
  • FTEL Nasdaq
  • Market Cap
  • INTS 8.4M
  • FTEL 9.8M
  • IPO Year
  • INTS 2023
  • FTEL 2023
  • Fundamental
  • Price
  • INTS $0.30
  • FTEL $0.46
  • Analyst Decision
  • INTS Strong Buy
  • FTEL
  • Analyst Count
  • INTS 4
  • FTEL 0
  • Target Price
  • INTS $4.50
  • FTEL N/A
  • AVG Volume (30 Days)
  • INTS 5.8M
  • FTEL 121.5K
  • Earning Date
  • INTS 08-07-2025
  • FTEL 04-28-2025
  • Dividend Yield
  • INTS N/A
  • FTEL N/A
  • EPS Growth
  • INTS N/A
  • FTEL N/A
  • EPS
  • INTS N/A
  • FTEL N/A
  • Revenue
  • INTS N/A
  • FTEL $4,990,695.00
  • Revenue This Year
  • INTS N/A
  • FTEL N/A
  • Revenue Next Year
  • INTS N/A
  • FTEL N/A
  • P/E Ratio
  • INTS N/A
  • FTEL N/A
  • Revenue Growth
  • INTS N/A
  • FTEL 29.02
  • 52 Week Low
  • INTS $0.19
  • FTEL $0.36
  • 52 Week High
  • INTS $4.35
  • FTEL $49.50
  • Technical
  • Relative Strength Index (RSI)
  • INTS 49.95
  • FTEL 40.03
  • Support Level
  • INTS $0.28
  • FTEL $0.44
  • Resistance Level
  • INTS $0.32
  • FTEL $0.50
  • Average True Range (ATR)
  • INTS 0.03
  • FTEL 0.04
  • MACD
  • INTS 0.01
  • FTEL -0.00
  • Stochastic Oscillator
  • INTS 78.80
  • FTEL 19.75

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About FTEL Fitell Corporation

Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.

Share on Social Networks: